AlanKivaLichtensteinMD

Professor, Medicine, UCLA School of Medicine

Dr. Lichtenstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
11301 Wilshire Blvd
Los Angeles, CA 90073
Phone+1 310-478-3711

Fax+1 310-268-4508

University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1977 - 1978
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1975 - 1977
UPMC Medical EducationResidency, Internal Medicine, 1972 - 1975
George Washington University School of Medicine and Health SciencesClass of 1972

PubMed

2 citations
Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.
Mario Vega, Yu Chen, Yijiang Shi, Joseph Gera, Alan Lichtenstein
The Journal of Biological Chemistry. 2022-04-01
4 citations
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
Yijiang Shi, Fumou Sun, Yan Cheng, Brent Holmes, Binod Dhakal
Molecular Cancer Therapeutics. 2022-04-01
4 citations
Function of Deptor and its roles in hematological malignancies.
Mario Morales-Martinez, Alan Lichtenstein, Mario I. Vega
Aging. 2021-01-07

Abstracts/Posters

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo
Alan Lichtenstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Regulation Of C-MYC Translation By Hnrnp A1: Role In Multiple Myeloma Tumor RespoNational Cancer Institute2009–2011
Use Of CCI-779 In Multiple MyelomaNational Cancer Institute2008–2009
Sensitivity Multiple Myeloma Cells To Mtor InhibitorsNational Cancer Institute2005–2009
EBV Lytic Re-Activation In Nasopharyngeal CarcinomaNational Cancer Institute2005–2006
The Akt-Mtor Pathway In Multiple MyelomaNational Cancer Institute2002–2005
Anti-Tumor Properties Of Acute InflammationNational Cancer Institute1985–1987